(Q38977597)

8 September 2017

1 reference

title

Diabetes management in older people: a focus on cardiovascular risk reduction (English)

1 reference

8 September 2017

Emily McNicholas

1 reference

8 September 2017

Ahmed H Abdelhafiz

series ordinal

1 reference

8 September 2017

language of work or name

English

0 references

publication date

11 October 2016

1 reference

8 September 2017

published in

Postgraduate Medicine

1 reference

8 September 2017

volume

129

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

169-177

1 reference

Diabetes in elderly adults

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Diabetes and coronary heart disease as risk factors for mortality in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

The changing face of diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Smoking status and risk for recurrent coronary events after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: an analysis of intervention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes-Network meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Current role of beta-blockers in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Aspirin for primary prevention of cardiovascular events in people with diabetes, etc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Underuse of cardioprotective treatment by the elderly with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Skeletal muscle loss: cachexia, sarcopenia, and inactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Lifestyle change and mobility in obese adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Efficacy of progressive resistance training interventions in older adults in nursing homes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Cardiometabolic determinants of mortality in a geriatric population: is there a "reverse metabolic syndrome"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Potential overtreatment of diabetes mellitus in older adults with tight glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Lower systolic blood pressure is associated with greater mortality in people aged 85 and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Can diabetes medication be reduced in elderly patients? An observational study of diabetes drug withdrawal in nursing home patients with tight glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2017.1246346

10.1080/00325481.2017.1246346

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference